EUVIMEDEUVIMED entdecken
Crossref

Nonsurgical Control of Seizure Threshold with Acoustically Targeted Chemogenetics

Honghao Li iD, Shirin Nouraein, Sangsin Lee iD, Schuyler S Link, Emma K Raisley iD, Jerzy O Szablowski iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Honghao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Rice University, Houston, Texas 77030, United States. Hauptthemen laut MEDLINE: Seizures, Genetic Therapy. Die Arbeit nennt 98 Literaturangaben. Gefördert von: National Science Foundation Graduate Research Fellowship Program, G. Harold and Leila Y. Mathers Charitable Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many neurological and psychiatric diseases are characterized by pathological neuronal activity. Current treatments involve drugs, surgeries, and implantable devices to modulate or remove the affected region. However, none of these methods can be simultaneously nonsurgical and possess site- and cell type specificity. Here, we apply a nonsurgical neuromodulation approach called Acoustically-Targeted Chemogenetics, or ATAC, to increase the seizure threshold. The ATAC approach used a multipoint focused ultrasound to transiently open the blood-brain barrier of the whole hippocampus (HPC) and transduce pyramidal neurons with engineered G-protein-coupled receptors to inhibit their activity. To express the engineered receptors in the mouse HPC, we used a recently engineered viral vector optimized for ultrasound-based gene delivery to the brain, AAV.FUS.3. In a mouse fluorothyl seizure model, we showed successful gene delivery throughout the HPC, a significant neuronal activity inhibition as evidenced by an increase in seizure threshold. Finally, we benchmarked these effects against a clinically prescribed drug that acts without spatial precision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeizuresGenetic TherapyAnimalsMiceGene Transfer TechniquesHippocampusBlood-Brain BarrierReceptors, G-Protein-CoupledMice, Inbred C57BLMalePyramidal CellsDisease Models, AnimalChemogenetics

Stichwörter der Autor:innen

blood–brain barrierbrainchemogeneticsgene therapyseizureultrasound

Substanzen

Receptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Bioengineering, Rice University, Houston, Texas 77030, United States.
  • Rice Neuroengineering Initiative, Rice University, Houston, Texas 77030, United States.
  • Synthetic, Systems, and Physical Biology Program, Rice University, Houston, Texas 77005, United States.
  • Applied Physics Program, Rice University, Houston, Texas 77005, United States.
  • Rice Synthetic Biology Institute, Rice University, Houston, Texas 77005, United States.

ORCID-Profile: Honghao Li, Sangsin Lee, Emma K Raisley, Jerzy O Szablowski

Förderung

  • National Science Foundation Graduate Research Fellowship Program
  • G. Harold and Leila Y. Mathers Charitable Foundation
  • National Institutes of Health

Zitieren

APA

Li, H., Nouraein, S., Lee, S., Link, S. S., Raisley, E. K., & Szablowski, J. O. (2025). Nonsurgical Control of Seizure Threshold with Acoustically Targeted Chemogenetics. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00404

Vancouver

Li H, Nouraein S, Lee S, Link SS, Raisley EK, Szablowski JO. Nonsurgical Control of Seizure Threshold with Acoustically Targeted Chemogenetics. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00404

BibTeX
@article{Li2025,
  author = {Li, Honghao and Nouraein, Shirin and Lee, Sangsin and Link, Schuyler S and Raisley, Emma K and Szablowski, Jerzy O},
  title = {Nonsurgical Control of Seizure Threshold with Acoustically Targeted Chemogenetics},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00404}
}
Kostenlos starten →